Idebenone treatment in Leber's hereditary optic neuropathy

Brain

Volumn 134, Issue 9, 2011, Pages 1-5

  Carelli, Valerio ^a   Morgia, Chiara La ^a   Valentino, Maria Lucia ^a   Rizzo, Giovanni ^a   Carbonelli, Michele ^b   De Negri, Anna Maria ^c   Sadun, Federico ^d   Carta, Arturo ^e   Guerriero, Silvana ^f   Simonelli, Francesca ^g   Sadun, Alfredo Arrigo ^h   Aggarwal, Divya ^h   Liguori, Rocco ^a   Avoni, Patrizia ^a   Baruzzi, Agostino ^a   Zeviani, Massimo ⁱ   Montagna, Pasquale ^a   Barboni, Piero ^a,j  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

^f UNIVERSITY OF BARI   (Italy)

^g SECOND UNIVERSITY OF NAPLES   (Italy)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ Unit of Molecular Neurogenetics   (Italy)

^j Studio Oculistico d'Azeglio   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; DRUG DERIVATIVE; DRUG THERAPY; IDEBENONE; MITOCHONDRIAL DNA; PLACEBO; UBIQUINONE;

DRUG DOSE INCREASE; DRUG EFFICACY; DRUG THERAPY; DRUG WITHDRAWAL; FEMALE; FRIEDREICH ATAXIA; HUMAN; INSOMNIA; LEBER HEREDITARY OPTIC NEUROPATHY; LETTER; MALE; NOTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX RATIO; TREATMENT DURATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

ANALOGS AND DERIVATIVES; ANTIOXIDANTS; DRUG THERAPY; FEMALE; HUMANS; MALE; OPTIC ATROPHY, HEREDITARY, LEBER; PLACEBOS; THERAPEUTIC USE; UBIQUINONE;

EID: 80052958201     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr180     Document Type: Letter

References (16)

1. Barboni P, Savini G, Valentino ML, Montagna P, Cortelli P, De Negri AM, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy. Ophthalmology 2005; 112: 120-6.
2. Barboni P, Savini G, Valentino ML, La Morgia C, Bellusci C, De Negri AM, et al. Leber's hereditary optic neuropathy with childhood onset. Invest Ophthalmol Vis Sci 2006; 47: 5303-9.
3. Barboni P, Carbonelli M, Savini G, Ramos Cdo V, Carta A, Berezovsky A, et al. Natural history of Leber's hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography. Ophthalmology 2010; 117: 623-7.
4. Carelli V, Barboni P, Zacchini A, Mancini R, Monari L, Cevoli S, et al. Leber's Hereditary Optic Neuropathy (LHON) with 14484/ND6 mutation in a North African patient. J Neurol Sci 1998a; 160: 183-8.
5. Carelli V, Ghelli A, Cevoli S, Cortelli P, Lugaresi E, Baruzzi A, et al. Idebenone therapy in Leber's hereditary optic neuropathy: report of six cases. Neurology 1998b; 50 (Suppl 4): A4.
6. Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Ret Eye Res 2004; 23: 58-89.
7. Klopstock T, Yu-Wai-Man P, Dimitriadis K, Rouleau J, Heck S, Bailie M, et al. RHODOS study. Brain 2011, (in press).
8. Cortelli P, Montagna P, Pierangeli G, Lodi R, Barboni P, Liguori R, et al. Clinical and brain bioenergetics improvement with idebenone in a patient with Leber's hereditary optic neuropathy: a clinical and 31P-MRS study. J Neurol Sci 1997; 148: 25-31.
9. Kearney M, Orrell RW, Fahey M, Pandolfo M. Antioxidants and other pharmacological treatments for Friedreich ataxia. Cochrane Database Syst Rev 2009; 4: CD007791.
10. Mashima Y, Hiida Y, Oguchi Y. Remission of Leber's hereditary optic neuropathy with idebenone. Lancet 1992; 340: 368-9.
11. Mashima Y, Kigasawa K, Wakakura M, Oguchi Y. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy? J Neuroophthalmol 2000; 20: 166-70.
12. Nikoskelainen E, Hoyt WF, Nummelin K. Ophthalmoscopic findings in Leber's hereditary optic neuropathy. II. The fundus findings in affected family members. Arch Ophthalmol 1983; 101: 1059-68.
13. Nikoskelainen EK, Huoponen K, Juvonen V, Lamminen T, Nummelin K, Savontaus ML. Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology 1996; 103: 504-14.
14. Rustin P, von Kleist-Retzow JC, Chantrel-Groussard K, Sidi D, Munnich A, Rö tig A. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 1999; 354: 477-9.
15. Spruijt L, Kolbach DN, de Coo RF, Plomp AS, Bauer NJ, Smeets HJ, et al. Influence of mutation type on clinical expression of Leber hereditary optic neuropathy. Am J Ophthalmol 2006; 141: 676-82.
16. Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies - Disease mechanisms and therapeutic strategies. Prog Retin Eye Res 2011; 30: 81-114.